FDA appoints veteran oncology chief Pazdur to lead drug center

FDA taps ‘visionary’ oncology leader to serve as top drug regulator

The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur joined the FDA in 1999 and recently served as founding director of the Oncology Center of Excellence.

Richard Pazdur, longtime FDA oncology leader, to head agency’s main drug office

The appointment of Pazdur as CDER head comes shortly after the surprise ousting of George Tidmarsh and should quiet many of the “lingering uncertainties” surrounding the FDA, wrote one industry analyst.

FDA appoints veteran Pazdur to replace Tidmarsh

The FDA has steadied the ship at CDER by naming veteran regulator Richard Pazdur as director, although he was reportedly reluctant to take the job

FDA Names Veteran Oncologist Richard Pazdur To Lead Drug Center After Ethics Scandal Ousts George Tidmarsh

The U.S. Food and Drug Administration has appointed Dr. Richard Pazdur to succeed Dr. George Tidmarsh as the new head of its drug center.

FDA Names New Top Drug Regulator

The Food and Drug Administration (FDA) said on Nov. 11 that Dr. Richard Pazdur, who had been in charge of regulating cancer drugs, will be the new director of the Center for Drug Evaluation and Research (CDER). Pazdur has worked at the FDA for 26 years and is the founding director of the FDA’s Oncology Center of Excellence. His other work at the agency included launching a new way to review cancer products that focused on speeding up the develop…

Longtime FDA oncology leader named agency’s top drug regulator

The US Food and Drug Administration said Tuesday that Dr. Richard Pazdur has been named head of the Center for Drug Evaluation and Research, its largest division, which oversees the safety and regulation of most prescription drugs and over-the-counter medicines.